Downloads: 1
| # | NCT00392327 | 400 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00632853 | 729 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | NCT00719303 | 1070 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | NCT00492778 | 164 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | NCT00001337 | 348 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | NCT00576654 | 36 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||
| 6 | NCT01012817 | 102 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | NCT00956007 | 700 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | NCT00887146 | 360 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosomes 1p/19q" | name:"1p/19q Codeletion" | synonyms:["Loss of Chromosomes 1p/19q" | 1p/19q Co-deletion | del(1p/19q)] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C79099" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"IDH1 Gene Mutation" | name:"IDH1 Gene Mutation" | synonyms:["IDH1 Mutation" | Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation | Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118389" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"IDH2 Gene Mutation" | name:"IDH2 Gene Mutation" | synonyms:["Isocitrate Dehydrogenase 1 (NADP+) | Mitochondrial Gene Mutation" | Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation | IDH2 Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118390" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||
| 9 | NCT00983697 | 292 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | NCT00980954 | 285 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | NCT00981656 | 37 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | NCT00980460 | 253 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | NCT01013649 | 545 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | NCT02085408 | 747 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | NCT01042522 | 128 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | NCT01096368 | 500 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | NCT01118026 | 100 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | NCT01101451 | 360 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | NCT01141231 | 240 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | NCT01366144 | 276 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | NCT01051635 | 74 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | NCT01222754 | 30 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | NCT01386385 | 162 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | NCT01381718 | 143 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | NCT01190930 | 9483 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | NCT01231906 | 693 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | NCT01272037 | 10000 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||
| 28 | NCT01359592 | 155 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CD20 Positive" | name:"CD20 Positive" | synonyms:["CD20 Expressing" | CD20 Present] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128631" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | NCT01368588 | 2580 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | NCT01434316 | 130 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA2 Gene Mutation" | name:"BRCA2 Gene Mutation" | synonyms:["Breast Cancer Type 2 Susceptibility Gene Mutation" | Mutation of the BRCA2 Gene | BRCA2 Mutation | Breast Cancer 2, Early Onset Gene Mutation | BROVCA2 Gene Mutation | Breast Cancer 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19636" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA1 Gene Mutation" | name:"BRCA1 Gene Mutation" | synonyms:["Breast Cancer 1 | Early Onset Gene Mutation" | BROVCA1 Gene Mutation | Breast Cancer 1 Gene Mutation | BRCA1 Mutation | Breast Cancer Type 1 Susceptibility Gene Mutation | Mutation of the BRCA1 Gene] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19635" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||
| 31 | NCT01497444 | 48 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | NCT01503632 | 608 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | NCT01503086 | 71 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | NCT01515787 | 1120 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | NCT01333046 | 44 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | NCT01556243 | 265 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | NCT01573442 | 224 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | NCT01587352 | 40 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | NCT01585805 | 107 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA2 Gene Mutation" | name:"BRCA2 Gene Mutation" | synonyms:["Breast Cancer Type 2 Susceptibility Gene Mutation" | Mutation of the BRCA2 Gene | BRCA2 Mutation | Breast Cancer 2, Early Onset Gene Mutation | BROVCA2 Gene Mutation | Breast Cancer 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19636" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA1 Gene Mutation" | name:"BRCA1 Gene Mutation" | synonyms:["Breast Cancer 1 | Early Onset Gene Mutation" | BROVCA1 Gene Mutation | Breast Cancer 1 Gene Mutation | BRCA1 Mutation | Breast Cancer Type 1 Susceptibility Gene Mutation | Mutation of the BRCA1 Gene] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19635" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"PALB2 Gene Mutation" | name:"PALB2 Gene Mutation" | synonyms:["FANCN Gene Mutation" | PNCA3 Gene Mutation | Fanconi Anemia, Complementation Group N Gene Mutation | Partner and Localizer of BRCA2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C101641" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||
| 40 | NCT01638533 | 132 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | NCT01775475 | 90 | [{assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"Human Immunodeficiency Virus 1 Positive" | name:"HIV-1 Positive" | synonyms:["HIV1 Positive" | Human Immunodeficiency Virus 1 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129253" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | NCT01695941 | 24 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | NCT01595061 | 52 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | NCT01602666 | 275 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | NCT01622868 | 143 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Positive" | name:"HER2/Neu Positive" | synonyms:["HER-2 Positive" | HER2 Positive | ERBB2 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68748" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ERBB2 Gene Amplification" | name:"HER2 Amplification" | synonyms:["ERBB2 Gene Amplification" | HER2/Neu Amplification | c-erbB2 Gene Amplification | HER-2 Gene Amplification | ERBB2 Amplification | c-erbB2 Gene Activation | HER2 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36638" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | NCT01649089 | 600 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | NCT01674140 | 1900 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||
| 48 | NCT01668719 | 130 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | NCT01711541 | 110 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | NCT01711554 | 62 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | NCT01781468 | 330 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | NCT01805076 | 317 | [{assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Positive" | name:"HER2/Neu Positive" | synonyms:["HER-2 Positive" | HER2 Positive | ERBB2 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68748" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"Deleterious BRCA1 Gene Mutation" | name:"Deleterious BRCA1 Gene Mutation" | synonyms:["Deleterious BROVCA1 Gene Mutation" | Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128814" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"Deleterious BRCA2 Gene Mutation" | name:"Deleterious BRCA2 Gene Mutation" | synonyms:["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation" | Deleterious BROVCA2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128815" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"}]" |
| 53 | NCT01730937 | 368 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | NCT01349881 | 491 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | NCT01789684 | 3780 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | NCT01863550 | 1080 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | NCT01749397 | 102 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | NCT01806129 | 612 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | NCT01586403 | 45 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Tyrosinase Positive" | name:"TYR Positive" | synonyms:["Tyrosinase Positive"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128846" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HLA-A2 Positive Cells Present" | name:"HLA-A*02 Positive" | synonyms:["HLA-A2 Positive Cells Present" | HLA-A*02 Positive Cells Present] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C69408" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | NCT01755195 | 55 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | NCT01767194 | 74 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | NCT01089101 | 180 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | NCT01872975 | 1636 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | NCT01771107 | 70 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Human Immunodeficiency Virus 1 Positive" | name:"HIV-1 Positive" | synonyms:["HIV1 Positive" | Human Immunodeficiency Virus 1 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129253" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | NCT01220583 | 252 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | NCT01824836 | 1000 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | NCT01810913 | 660 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | NCT01817075 | 450 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | NCT00978250 | 165 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | NCT01822496 | 234 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | NCT01822509 | 113 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | NCT01822522 | 42 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HIV Positivity" | name:"HIV Positive" | synonyms:["HIV Positivity" | Human Immunodeficiency Virus Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15175" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | NCT01244737 | 75 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | NCT01841723 | 44 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | NCT01849146 | 36 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | NCT01901094 | 2918 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | NCT01851369 | 140 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | NCT01935934 | 72 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | NCT01881867 | 80 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Castration Levels of Testosterone" | name:"Castration Levels of Testosterone" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129259" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | NCT01534598 | 68 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | NCT01897012 | 42 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"MYC Positive" | name:"Myc Positive" | synonyms:["c-MYC Positive" | Myc Proto-Oncogene Positive | Proto-Oncogene c-Myc Positive | v-myc Avian Myelocytomatosis Viral Oncogene Cellular Homolog Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131061" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | NCT01896999 | 189 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | NCT01902173 | 97 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF V600 Protein Variation" | name:"BRAF V600 Mutation" | synonyms:["BRAF NP_004324.2:p.V600 Mutation" | BRAF NP_004324.2:p.Val600 Mutation | BRAF p.Val600 Mutation | BRAF p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation | NP_004324.2:p.Val600 Mutation | NP_004324.2:p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C105823" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | NCT01953588 | 2060 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | NCT01912625 | 30 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"KRAS Activating Mutation" | name:"Activating KRAS Mutation" | synonyms:["KRAS-2 Activating Mutation" | KRAS Activating Mutation | c-K-ras Activating Mutation | KRAS2 Activating Mutation | KRAS Proto-Oncogene, GTPase Activating Mutation | v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Activating Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118391" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | NCT01925131 | 38 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Blasts 5 Percent or More of Peripheral Blood White Cells" | name:"Blasts 5 Percent or More of Peripheral Blood White Cells" | synonyms:["Blasts Greater than or Equal to 5 Percent of Peripheral Blood White Cells"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C141299" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CD22 Positive" | name:"CD22 Positive" | synonyms:["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive" | SIGLEC-2 Positive | CD22 Molecule Positive | BL-CAM Positive | B-Cell Receptor CD22 Positive | T-Cell Surface Antigen Leu-14 Positive | SIGLEC2 Positive | B-Lymphocyte Cell Adhesion Molecule Positive | CD22 Antigen Positive | Sialic Acid-Binding Ig-Like Lectin 2 Positive | B-Cell Antigen CD22 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131066" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Philadelphia Chromosome Positive" | name:"Philadelphia Chromosome Positive" | synonyms:["Ph Positive"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128843" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Blasts 5 Percent or More of Bone Marrow Nucleated Cells" | name:"Blasts 5 Percent or More of Bone Marrow Nucleated Cells" | synonyms:["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136411" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||
| 87 | NCT00942877 | 73 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | NCT01273155 | 80 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | NCT01273168 | 72 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Positive" | name:"HER2/Neu Positive" | synonyms:["HER-2 Positive" | HER2 Positive | ERBB2 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68748" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||
| 90 | NCT01362803 | 104 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | NCT01391962 | 70 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | NCT01572493 | 52 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | NCT01748825 | 72 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA2 Gene Mutation" | name:"BRCA2 Gene Mutation" | synonyms:["Breast Cancer Type 2 Susceptibility Gene Mutation" | Mutation of the BRCA2 Gene | BRCA2 Mutation | Breast Cancer 2, Early Onset Gene Mutation | BROVCA2 Gene Mutation | Breast Cancer 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19636" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA1 Gene Mutation" | name:"BRCA1 Gene Mutation" | synonyms:["Breast Cancer 1 | Early Onset Gene Mutation" | BROVCA1 Gene Mutation | Breast Cancer 1 Gene Mutation | BRCA1 Mutation | Breast Cancer Type 1 Susceptibility Gene Mutation | Mutation of the BRCA1 Gene] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19635" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||
| 94 | NCT01827384 | 700 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | NCT01922076 | 77 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"H3 K27M Mutation" | name:"Histone 3 K27M Mutation" | synonyms:["Histone H3 K28M" | H3 K28M Mutation | H3 Lys28Met | H3 K27M | Histone H3 Lys27Met | H3 K28M | Histone H3 Lys28Met | H3 Lys27Met | Histone H3 K27M | H3 p.Lys28Met | H3 K27M Mutation | H3 p.K28M] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129310" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | NCT01964300 | 52 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | NCT02004275 | 97 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | NCT01940809 | 40 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600K Chromosomal mutation" | name:"BRAF V600K Mutation" | synonyms:["BRAF p.Val600Lys" | BRAF NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf V600K | NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf Val600Lys | BRAF NP_004324.2:p.V600K | BRAF p.V600K | B-RAF1 c.1798_1799GT>AA] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98348:C98347" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF V600 Protein Variation" | name:"BRAF V600 Mutation" | synonyms:["BRAF NP_004324.2:p.V600 Mutation" | BRAF NP_004324.2:p.Val600 Mutation | BRAF p.Val600 Mutation | BRAF p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation | NP_004324.2:p.Val600 Mutation | NP_004324.2:p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C105823" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"RAS Family Gene Mutation" | name:"RAS Family Gene Mutation" | synonyms:["RAS Mutation" | RAS Family Mutation | Mutant RAS Family Gene | Mutant RAS] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C132229" | eligibility_criterion:"exclusion"}]" | |||||||||||||||||||||||||||||||
| 99 | NCT01947023 | 18 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600E" | name:"BRAF V600E Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98342" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600K Chromosomal mutation" | name:"BRAF V600K Mutation" | synonyms:["BRAF p.Val600Lys" | BRAF NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf V600K | NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf Val600Lys | BRAF NP_004324.2:p.V600K | BRAF p.V600K | B-RAF1 c.1798_1799GT>AA] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98348:C98347" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | NCT01988571 | 278 | null |